- Home
- VYNE vs SNES Comparison
VYNE vs SNES Comparison
Compare VYNE & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- SNES
- Stock Information
- Founded
- VYNE 2003
- SNES 2004
- Country
- VYNE United States
- SNES United States
- Employees
- VYNE N/A
- SNES N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- VYNE Health Care
- SNES Industrials
- Exchange
- VYNE Nasdaq
- SNES Nasdaq
- Market Cap
- VYNE 24.3M
- SNES 21.0M
- IPO Year
- VYNE 2018
- SNES 2016
- Fundamental
- Price
- VYNE $0.35
- SNES $4.67
- Analyst Decision
- VYNE Buy
- SNES Strong Buy
- Analyst Count
- VYNE 2
- SNES 1
- Target Price
- VYNE $8.00
- SNES $10.00
- AVG Volume (30 Days)
- VYNE 4.1M
- SNES 195.8K
- Earning Date
- VYNE 08-14-2025
- SNES 08-07-2025
- Dividend Yield
- VYNE N/A
- SNES N/A
- EPS Growth
- VYNE N/A
- SNES N/A
- EPS
- VYNE N/A
- SNES N/A
- Revenue
- VYNE $476,000.00
- SNES $2,093,000.00
- Revenue This Year
- VYNE $42.51
- SNES $130.53
- Revenue Next Year
- VYNE N/A
- SNES $80.00
- P/E Ratio
- VYNE N/A
- SNES N/A
- Revenue Growth
- VYNE N/A
- SNES 36.89
- 52 Week Low
- VYNE $0.33
- SNES $1.30
- 52 Week High
- VYNE $4.30
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- VYNE 29.46
- SNES 46.89
- Support Level
- VYNE $0.35
- SNES $4.47
- Resistance Level
- VYNE $0.36
- SNES $6.24
- Average True Range (ATR)
- VYNE 0.04
- SNES 0.41
- MACD
- VYNE -0.02
- SNES -0.13
- Stochastic Oscillator
- VYNE 1.79
- SNES 19.03
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.